Search

A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.

… Wednesday, March 29, 2023 Highlights MSK researchers identified a key role for the STING signaling pathway in preventing dormant metastatic cancer cells from progressing to active metastases. Treating laboratory mice with a STING activator helped eliminate lingering metastatic cells and stop the development

An innovative technique called stereotactic hypofractionated accelerated radiation to the prostate – aka SHARP - safely and effectively delivers powerful doses of radiation directly to the patient’s tumor with incredible precision.

… Friday, June 2, 2017 For decades, experts at Memorial Sloan Kettering have been pioneering sophisticated ways to safely and effectively deliver powerful doses of radiation directly to a person’s tumor with incredible precision. One recent example of these ongoing efforts is an innovative technique called

New MSK research showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and sheds new light on cell state changes in prostate cancer.

… Wednesday, July 31, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) showed giving chemotherapy shortly after a stem cell or bone marrow transplant from a less than perfectly matched donor greatly reduces the chances that the patient will develop graft-versus-host disease (GVHD); and

Recent data from Memorial Sloan Kettering shows that a real-time breast ultrasound exam after second opinion review of outside, static breast ultrasound images led to a change in the initially prescribed management in 32.5 percent of included patients.

… Monday, October 16, 2017 Asymptomatic women who undergo routine breast cancer screening with imaging may be uncertain of the next steps when an unexpected suspicious finding or cancer is reported in the context of their annual visit with a primary care doctor in the community setting. For these women

Traveling with cancer can be done, even if you’re in active treatment. Plan ahead so that you can fully enjoy your vacation.

… Thursday, June 30, 2016 Summary Having cancer doesn’t mean you can’t visit loved ones and exciting locales. Learn how to make the most of your travels if you’re currently in active treatment. Highlights You can minimize the stress of traveling by planning and preparing in advance. Check in with your

A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems.

… Monday, February 3, 2014 A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems. The $6.7 million project may translate into new treatments that benefit older people and those who have received a bone marrow transplant. The initiative – called

Diane Reidy-Lagunes sits down with Mary Elizabeth Williams to discuss what it was like being part of a phase 1 clinical trial, how clear communication can affect health outcomes, how guilt often accompanies survival, and what not to say to a cancer patient.

… Monday, November 29, 2021 When Mary Elizabeth Williams was diagnosed with stage 4 melanoma, she says: “My identity and my relationship with my mortality changed. That was the beginning of my new life.” Her decision to publicly disclose her diagnosis soon after receiving it was easy, she says. “I went

Data from 25,000 patients is helping scientists answer this and many other important questions.

… Thursday, February 3, 2022 Several years ago, in a lab meeting, one of Nikolaus Schultz’s postdoctoral fellows posed a question: “Do you think it’s possible to predict, based on the genomic profile of an individual tumor, which organs it might metastasize to?” And just like that, a research project was

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate Member of the Immunology Program at the Sloan Kettering Institute will be honored at the 2023 American Association for Cancer Research (AACR) Annual Meeting for their significant contributions to cancer research and care.

… Friday, April 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS , President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD , Associate Member of the Immunology Program at the Sloan Kettering Institute will be honored at the

Learn how blood tests called liquid biopsies may be used to find, diagnose, and treat cancer anywhere in the body.

… Monday, September 15, 2025 A blood test to find cancer even before it shows any symptoms is the dream of cancer doctors everywhere.   Researchers at Memorial Sloan Kettering Cancer Center (MSK) are among those hard at work on developing a test that can accurately pick up signs of a tumor anywhere in